Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 1
1967 2
1970 1
1971 5
1972 5
1973 7
1974 7
1975 6
1976 6
1977 4
1978 7
1979 5
1980 3
1981 5
1982 2
1983 5
1984 12
1985 8
1986 5
1987 21
1988 10
1989 12
1990 11
1991 11
1992 8
1993 14
1994 22
1995 12
1996 14
1997 14
1998 16
1999 22
2000 22
2001 21
2002 19
2003 30
2004 19
2005 22
2006 15
2007 20
2008 15
2009 18
2010 24
2011 27
2012 18
2013 23
2014 15
2015 14
2016 19
2017 14
2018 16
2019 16
2020 14
2021 14
2022 11
2023 7
2024 7
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

696 results

Results by year

Filters applied: . Clear all
Page 1
Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial.
Crees ZD, Rettig MP, Jayasinghe RG, Stockerl-Goldstein K, Larson SM, Arpad I, Milone GA, Martino M, Stiff P, Sborov D, Pereira D, Micallef I, Moreno-Jiménez G, Mikala G, Coronel MLP, Holtick U, Hiemenz J, Qazilbash MH, Hardy N, Latif T, García-Cadenas I, Vainstein-Haras A, Sorani E, Gliko-Kabir I, Goldstein I, Ickowicz D, Shemesh-Darvish L, Kadosh S, Gao F, Schroeder MA, Vij R, DiPersio JF. Crees ZD, et al. Among authors: larson sm. Nat Med. 2023 Apr;29(4):869-879. doi: 10.1038/s41591-023-02273-z. Epub 2023 Apr 17. Nat Med. 2023. PMID: 37069359 Free PMC article. Clinical Trial.
Engineering allorejection-resistant CAR-NKT cells from hematopoietic stem cells for off-the-shelf cancer immunotherapy.
Li YR, Zhou Y, Yu J, Zhu Y, Lee D, Zhu E, Li Z, Kim YJ, Zhou K, Fang Y, Lyu Z, Chen Y, Tian Y, Huang J, Cen X, Husman T, Cho JM, Hsiai T, Zhou JJ, Wang P, Puliafito BR, Larson SM, Yang L. Li YR, et al. Among authors: larson sm. Mol Ther. 2024 Jun 5;32(6):1849-1874. doi: 10.1016/j.ymthe.2024.04.005. Epub 2024 Apr 6. Mol Ther. 2024. PMID: 38584391 Free PMC article.
CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma.
Larson SM, Walthers CM, Ji B, Ghafouri SN, Naparstek J, Trent J, Chen JM, Roshandell M, Harris C, Khericha M, Schweppe T, Berent-Maoz B, Gosliner SB, Almaktari A, Ceja MA, Allen-Auerbach MS, Said J, Nawaly K, Mead M, de Vos S, Young PA, Oliai C, Schiller GJ, Timmerman JM, Ribas A, Chen YY. Larson SM, et al. Cancer Discov. 2023 Mar 1;13(3):580-597. doi: 10.1158/2159-8290.CD-22-0964. Cancer Discov. 2023. PMID: 36416874 Free PMC article.
Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applications.
Kurtz K, Eibler L, Dacek MM, Carter LM, Veach DR, Lovibond S, Reynaud E, Qureshy S, McDevitt MR, Bourne C, Monette S, Punzalan B, Khayat S, Verma S, Kesner AL, Cheung NV, Schöder H, Gajecki L, Cheal SM, Larson SM, Scheinberg DA, Krebs S. Kurtz K, et al. Among authors: larson sm. Theranostics. 2023 Oct 8;13(15):5469-5482. doi: 10.7150/thno.87489. eCollection 2023. Theranostics. 2023. PMID: 37908719 Free PMC article.
Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture method.
Li YR, Zhou Y, Yu J, Kim YJ, Li M, Lee D, Zhou K, Chen Y, Zhu Y, Wang YC, Li Z, Yu Y, Dunn ZS, Guo W, Cen X, Husman T, Bajpai A, Kramer A, Wilson M, Fang Y, Huang J, Li S, Zhou Y, Zhang Y, Hahn Z, Zhu E, Ma F, Pan C, Lusis AJ, Zhou JJ, Seet CS, Kohn DB, Wang P, Zhou XJ, Pellegrini M, Puliafito BR, Larson SM, Yang L. Li YR, et al. Among authors: larson sm. Nat Biotechnol. 2025 Mar;43(3):329-344. doi: 10.1038/s41587-024-02226-y. Epub 2024 May 14. Nat Biotechnol. 2025. PMID: 38744947 Free PMC article.
Radioimmunotherapy of human tumours.
Larson SM, Carrasquillo JA, Cheung NK, Press OW. Larson SM, et al. Nat Rev Cancer. 2015 Jun;15(6):347-60. doi: 10.1038/nrc3925. Nat Rev Cancer. 2015. PMID: 25998714 Free PMC article. Review.
Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer.
Zhu Y, Smith DJ, Zhou Y, Li YR, Yu J, Lee D, Wang YC, Di Biase S, Wang X, Hardoy C, Ku J, Tsao T, Lin LJ, Pham AT, Moon H, McLaughlin J, Cheng D, Hollis RP, Campo-Fernandez B, Urbinati F, Wei L, Pang L, Rezek V, Berent-Maoz B, Macabali MH, Gjertson D, Wang X, Galic Z, Kitchen SG, An DS, Hu-Lieskovan S, Kaplan-Lefko PJ, De Oliveira SN, Seet CS, Larson SM, Forman SJ, Heath JR, Zack JA, Crooks GM, Radu CG, Ribas A, Kohn DB, Witte ON, Yang L. Zhu Y, et al. Among authors: larson sm. Cell Stem Cell. 2019 Oct 3;25(4):542-557.e9. doi: 10.1016/j.stem.2019.08.004. Epub 2019 Sep 5. Cell Stem Cell. 2019. PMID: 31495780 Free PMC article.
Oncology.
Larson SM. Larson SM. J Nucl Med. 2010 Sep;51(9):19N-25N. J Nucl Med. 2010. PMID: 20810752 Free article. No abstract available.
Pretargeting: A Path Forward for Radioimmunotherapy.
Cheal SM, Chung SK, Vaughn BA, Cheung NV, Larson SM. Cheal SM, et al. Among authors: larson sm. J Nucl Med. 2022 Sep;63(9):1302-1315. doi: 10.2967/jnumed.121.262186. J Nucl Med. 2022. PMID: 36215514 Free PMC article. Review.
696 results